1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Interferon
1.2.3 Immunomodulator
1.2.4 Immunosuppressant
1.3 Market by Application
1.3.1 Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Multiple Sclerosis Drugs Treatment Market Perspective (2017-2028)
2.2 Multiple Sclerosis Drugs Treatment Growth Trends by Region
2.2.1 Multiple Sclerosis Drugs Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Multiple Sclerosis Drugs Treatment Historic Market Size by Region (2017-2022)
2.2.3 Multiple Sclerosis Drugs Treatment Forecasted Market Size by Region (2023-2028)
2.3 Multiple Sclerosis Drugs Treatment Market Dynamics
2.3.1 Multiple Sclerosis Drugs Treatment Industry Trends
2.3.2 Multiple Sclerosis Drugs Treatment Market Drivers
2.3.3 Multiple Sclerosis Drugs Treatment Market Challenges
2.3.4 Multiple Sclerosis Drugs Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiple Sclerosis Drugs Treatment Players by Revenue
3.1.1 Global Top Multiple Sclerosis Drugs Treatment Players by Revenue (2017-2022)
3.1.2 Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Multiple Sclerosis Drugs Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiple Sclerosis Drugs Treatment Revenue
3.4 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio
3.4.1 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Drugs Treatment Revenue in 2021
3.5 Multiple Sclerosis Drugs Treatment Key Players Head office and Area Served
3.6 Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
3.7 Date of Enter into Multiple Sclerosis Drugs Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Sclerosis Drugs Treatment Breakdown Data by Type
4.1 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Type (2017-2022)
4.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2023-2028)
5 Multiple Sclerosis Drugs Treatment Breakdown Data by Application
5.1 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Application (2017-2022)
5.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
6.2 North America Multiple Sclerosis Drugs Treatment Market Size by Type
6.2.1 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
6.2.2 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
6.2.3 North America Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
6.3 North America Multiple Sclerosis Drugs Treatment Market Size by Application
6.3.1 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
6.3.2 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
6.3.3 North America Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
6.4 North America Multiple Sclerosis Drugs Treatment Market Size by Country
6.4.1 North America Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022)
6.4.2 North America Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
7.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Type
7.2.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
7.2.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
7.2.3 Europe Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
7.3 Europe Multiple Sclerosis Drugs Treatment Market Size by Application
7.3.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
7.3.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
7.3.3 Europe Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
7.4 Europe Multiple Sclerosis Drugs Treatment Market Size by Country
7.4.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022)
7.4.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
8.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type
8.2.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application
8.3.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region
8.4.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
9.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type
9.2.1 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
9.3 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application
9.3.1 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
9.4 Latin America Multiple Sclerosis Drugs Treatment Market Size by Country
9.4.1 Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
10.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type
10.2.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application
10.3.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country
10.4.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Multiple Sclerosis Drugs Treatment Introduction
11.1.4 Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Multiple Sclerosis Drugs Treatment Introduction
11.2.4 Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Multiple Sclerosis Drugs Treatment Introduction
11.3.4 Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.3.5 Biogen Recent Developments
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.4.5 Teva Pharmaceutical Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Multiple Sclerosis Drugs Treatment Introduction
11.5.4 Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.5.5 Merck Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Multiple Sclerosis Drugs Treatment Introduction
11.6.4 Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Multiple Sclerosis Drugs Treatment Introduction
11.7.4 Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.7.5 Bayer Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Multiple Sclerosis Drugs Treatment Introduction
11.8.4 Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.8.5 Sanofi Recent Developments
11.9 Acorda Therapeutics
11.9.1 Acorda Therapeutics Company Details
11.9.2 Acorda Therapeutics Business Overview
11.9.3 Acorda Therapeutics Multiple Sclerosis Drugs Treatment Introduction
11.9.4 Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.9.5 Acorda Therapeutics Recent Developments
11.10 Questcor Pharmaceuticals
11.10.1 Questcor Pharmaceuticals Company Details
11.10.2 Questcor Pharmaceuticals Business Overview
11.10.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Introduction
11.10.4 Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.10.5 Questcor Pharmaceuticals Recent Developments
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Multiple Sclerosis Drugs Treatment Introduction
11.11.4 AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.11.5 AbbVie Recent Developments
11.12 Opexa Therapeutics
11.12.1 Opexa Therapeutics Company Details
11.12.2 Opexa Therapeutics Business Overview
11.12.3 Opexa Therapeutics Multiple Sclerosis Drugs Treatment Introduction
11.12.4 Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.12.5 Opexa Therapeutics Recent Developments
11.13 Genzyme Corporation
11.13.1 Genzyme Corporation Company Details
11.13.2 Genzyme Corporation Business Overview
11.13.3 Genzyme Corporation Multiple Sclerosis Drugs Treatment Introduction
11.13.4 Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
11.13.5 Genzyme Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Interferon
Table 3. Key Players of Immunomodulator
Table 4. Key Players of Immunosuppressant
Table 5. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Multiple Sclerosis Drugs Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Multiple Sclerosis Drugs Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Multiple Sclerosis Drugs Treatment Market Share by Region (2017-2022)
Table 9. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Multiple Sclerosis Drugs Treatment Market Share by Region (2023-2028)
Table 11. Multiple Sclerosis Drugs Treatment Market Trends
Table 12. Multiple Sclerosis Drugs Treatment Market Drivers
Table 13. Multiple Sclerosis Drugs Treatment Market Challenges
Table 14. Multiple Sclerosis Drugs Treatment Market Restraints
Table 15. Global Multiple Sclerosis Drugs Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Multiple Sclerosis Drugs Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Multiple Sclerosis Drugs Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2021)
Table 18. Ranking of Global Top Multiple Sclerosis Drugs Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Multiple Sclerosis Drugs Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
Table 22. Date of Enter into Multiple Sclerosis Drugs Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Multiple Sclerosis Drugs Treatment Revenue Share by Application (2017-2022)
Table 30. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Multiple Sclerosis Drugs Treatment Revenue Share by Application (2023-2028)
Table 32. North America Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Multiple Sclerosis Drugs Treatment Product
Table 65. Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Multiple Sclerosis Drugs Treatment Product
Table 70. Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 71. Roche Recent Developments
Table 72. Biogen Company Details
Table 73. Biogen Business Overview
Table 74. Biogen Multiple Sclerosis Drugs Treatment Product
Table 75. Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 76. Biogen Recent Developments
Table 77. Teva Pharmaceutical Company Details
Table 78. Teva Pharmaceutical Business Overview
Table 79. Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Product
Table 80. Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 81. Teva Pharmaceutical Recent Developments
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Multiple Sclerosis Drugs Treatment Product
Table 85. Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 86. Merck Recent Developments
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Multiple Sclerosis Drugs Treatment Product
Table 90. Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 91. Novartis Recent Developments
Table 92. Bayer Company Details
Table 93. Bayer Business Overview
Table 94. Bayer Multiple Sclerosis Drugs Treatment Product
Table 95. Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 96. Bayer Recent Developments
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Multiple Sclerosis Drugs Treatment Product
Table 100. Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 101. Sanofi Recent Developments
Table 102. Acorda Therapeutics Company Details
Table 103. Acorda Therapeutics Business Overview
Table 104. Acorda Therapeutics Multiple Sclerosis Drugs Treatment Product
Table 105. Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 106. Acorda Therapeutics Recent Developments
Table 107. Questcor Pharmaceuticals Company Details
Table 108. Questcor Pharmaceuticals Business Overview
Table 109. Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Product
Table 110. Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 111. Questcor Pharmaceuticals Recent Developments
Table 112. AbbVie Company Details
Table 113. AbbVie Business Overview
Table 114. AbbVie Multiple Sclerosis Drugs Treatment Product
Table 115. AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 116. AbbVie Recent Developments
Table 117. Opexa Therapeutics Company Details
Table 118. Opexa Therapeutics Business Overview
Table 119. Opexa Therapeutics Multiple Sclerosis Drugs Treatment Product
Table 120. Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 121. Opexa Therapeutics Recent Developments
Table 122. Genzyme Corporation Company Details
Table 123. Genzyme Corporation Business Overview
Table 124. Genzyme Corporation Multiple Sclerosis Drugs Treatment Product
Table 125. Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
Table 126. Genzyme Corporation Recent Developments
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Sclerosis Drugs Treatment Market Share by Type: 2021 VS 2028
Figure 2. Interferon Features
Figure 3. Immunomodulator Features
Figure 4. Immunosuppressant Features
Figure 5. Global Multiple Sclerosis Drugs Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Multiple Sclerosis Drugs Treatment Report Years Considered
Figure 11. Global Multiple Sclerosis Drugs Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Multiple Sclerosis Drugs Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Multiple Sclerosis Drugs Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Multiple Sclerosis Drugs Treatment Market Share by Players in 2021
Figure 15. Global Top Multiple Sclerosis Drugs Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Multiple Sclerosis Drugs Treatment Revenue in 2021
Figure 17. North America Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America Multiple Sclerosis Drugs Treatment Market Size Share by Country (2017-2028)
Figure 21. United States Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe Multiple Sclerosis Drugs Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size Share by Region (2017-2028)
Figure 37. China Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Multiple Sclerosis Drugs Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 57. Roche Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 58. Biogen Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 60. Merck Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 62. Bayer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 63. Sanofi Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 64. Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 65. Questcor Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 66. AbbVie Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 67. Opexa Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 68. Genzyme Corporation Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed